238 related articles for article (PubMed ID: 17018124)
1. Persistent cytomegalovirus infection in kidney allografts is associated with inferior graft function and survival.
Helanterä I; Koskinen P; Finne P; Loginov R; Kyllönen L; Salmela K; Grönhagen-Riska C; Lautenschlager I
Transpl Int; 2006 Nov; 19(11):893-900. PubMed ID: 17018124
[TBL] [Abstract][Full Text] [Related]
2. Persistent cytomegalovirus infection is associated with increased expression of TGF-beta1, PDGF-AA and ICAM-1 and arterial intimal thickening in kidney allografts.
Helanterä I; Loginov R; Koskinen P; Törnroth T; Grönhagen-Riska C; Lautenschlager I
Nephrol Dial Transplant; 2005 Apr; 20(4):790-6. PubMed ID: 15716293
[TBL] [Abstract][Full Text] [Related]
3. The impact of cytomegalovirus infections and acute rejection episodes on the development of vascular changes in 6-month protocol biopsy specimens of cadaveric kidney allograft recipients.
Helantera I; Koskinen P; Tornroth T; Loginov R; Gronhagen-Riska C; Lautenschlager I
Transplantation; 2003 Jun; 75(11):1858-64. PubMed ID: 12811246
[TBL] [Abstract][Full Text] [Related]
4. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A
Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of HHV-6 antigens in biopsies of kidney transplant recipients with cytomegalovirus infection.
Helanterä I; Loginov R; Koskinen P; Lautenschlager I
Transpl Int; 2008 Oct; 21(10):980-4. PubMed ID: 18564986
[TBL] [Abstract][Full Text] [Related]
6. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
[TBL] [Abstract][Full Text] [Related]
7. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
[TBL] [Abstract][Full Text] [Related]
8. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
[TBL] [Abstract][Full Text] [Related]
9. Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies.
Erdbruegger U; Scheffner I; Mengel M; Schwarz A; Verhagen W; Haller H; Gwinner W
Nephrol Dial Transplant; 2012 Jan; 27(1):435-43. PubMed ID: 21712490
[TBL] [Abstract][Full Text] [Related]
10. Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival.
Dzabic M; Rahbar A; Yaiw KC; Naghibi M; Religa P; Fellström B; Larsson E; Söderberg-Nauclér C
Clin Infect Dis; 2011 Nov; 53(10):969-76. PubMed ID: 21960711
[TBL] [Abstract][Full Text] [Related]
11. The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
Reischig T; Jindra P; Svecová M; Kormunda S; Opatrný K; Treska V
J Clin Virol; 2006 Jun; 36(2):146-51. PubMed ID: 16531113
[TBL] [Abstract][Full Text] [Related]
12. Increased urinary excretion of transforming growth factor-beta(1) in renal transplant recipients during cytomegalovirus infection.
Helanterä I; Teppo AM; Koskinen P; Törnroth T; Grönhagen-Riska C; Lautenschlager I
Transpl Immunol; 2006 Jan; 15(3):217-21. PubMed ID: 16431289
[TBL] [Abstract][Full Text] [Related]
13. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
Chen JH; Mao YY; He Q; Wu JY; Lv R
Transplant Proc; 2005 Dec; 37(10):4203-7. PubMed ID: 16387078
[TBL] [Abstract][Full Text] [Related]
14. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis.
Rayes N; Seehofer D; Kahl A; Kokott S; Pratschke J; Frei U; Neuhaus P
Transpl Int; 2007 Nov; 20(11):974-81. PubMed ID: 17680782
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus infection: a quantitative prospective study of three hundred twenty consecutive renal transplants.
Marker SC; Howard RJ; Simmons RL; Kalis JM; Connelly DP; Najarian JS; Balfour HH
Surgery; 1981 Jun; 89(6):660-71. PubMed ID: 6264640
[TBL] [Abstract][Full Text] [Related]
17. Long-term impact of CMV infection on allografts and on patient survival in renal transplant patients with protocol biopsies.
Erdbrügger U; Scheffner I; Mengel M; Schwarz A; Haller H; Gwinner W
Am J Physiol Renal Physiol; 2015 Dec; 309(11):F925-32. PubMed ID: 26354882
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk.
Sagedal S; Rollag H; Hartmann A
Clin Transplant; 2007; 21(3):309-13. PubMed ID: 17488378
[TBL] [Abstract][Full Text] [Related]
19. Probabilistic modeling of cytomegalovirus infection under consensus clinical management guidelines.
Dmitrienko S; Balshaw R; Machnicki G; Shapiro RJ; Keown PA
Transplantation; 2009 Feb; 87(4):570-7. PubMed ID: 19307796
[TBL] [Abstract][Full Text] [Related]
20. [Effect of cytomegalovirus infection on long-term renal allograft function].
Tang B; Lv PY; Xu FY; Zheng KL; Liu D
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1588-91. PubMed ID: 19726300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
